| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF00688529 |
| P698 | PubMed publication ID | 7376831 |
| P2093 | author name string | M Adachi | |
| D Amsterdam | |||
| S E Brooks | |||
| L Schneck | |||
| L M Hoffman | |||
| P2860 | cites work | Alterations of astrocytic organelles in various lipidoses and allied diseases | Q48874070 |
| The pattern of mammalian brain gangliosides. II. Evaluation of the extraction procedures, postmortem changes and the effect of formalin preservation | Q51250426 | ||
| Studies in Tay-Sachs disease. II. Ultrastructure of the cerebrum. | Q51290448 | ||
| Introduction of purified hexosaminidase A into Tay-Sachs leukocytes by means of immunoglobulin-coated liposomes. | Q52477095 | ||
| Concanavalin A mediated uptake of enzymes by fibroblasts | Q67441409 | ||
| The transport of lysosomal enzymes | Q67658695 | ||
| Concanavalin A toxicity: histological studies | Q67870578 | ||
| A recognition marker required for uptake of a lysosomal enzyme by cultured fibroblasts | Q68684301 | ||
| In Vivo Toxicity of Concanavalin A | Q68924026 | ||
| The Tay-Sachs disease fibroblast model: failure to respond to exogenous hexosaminidase A | Q69555912 | ||
| In vitro correction of deficient human fibroblasts by beta-glucuronidase from different human sources | Q69820185 | ||
| Glycosphingolipids in cultured human skin fibroblasts. II. Characterization and metabolism in fibroblasts from patients with inborn errors of glycosphingolipid and mucopolysaccharide metabolism | Q70445223 | ||
| Protein measurement with the Folin phenol reagent | Q20900776 | ||
| Phosphohexosyl recognition is a general characteristic of pinocytosis of lysosomal glycosidases by human fibroblasts | Q28332962 | ||
| Phosphohexosyl components of a lysosomal enzyme are recognized by pinocytosis receptors on human fibroblasts | Q35027280 | ||
| A general method for the introduction of enzymes, by means of immunoglobulin-coated liposomes, into lysosomes of deficient cells | Q35066086 | ||
| Hair-roots in screening and diagnosis of Tay-Sachs disease | Q39419478 | ||
| Lectin-mediated uptake of lysosomal hydrolases by genetically deficient human fibroblasts | Q39659849 | ||
| Ultrastructural alterations of tissue cultures from human fetal brain infected with the E variant of EMC virus | Q39955041 | ||
| Cytology, growth characteristics and cellular alterations following SV40-induced transformation of human foetal brain cells derived from a Gm2 gangliosidosis and control | Q40281154 | ||
| Pinocytosis in fibroblasts. Quantitative studies in vitro | Q41189675 | ||
| Effect of lectins on endocytosis and secretion of lysosomal enzymes by cultures fibroblasts | Q41608058 | ||
| Purification and properties of human kidney-cortex hexosaminidases A and B. | Q41840309 | ||
| Liposomes containing Antiviral Antibody can protect Cells from Virus Infection | Q45816496 | ||
| Fetal Tay-Sachs disease brain cells in culture: lack of turnover in [(14)C]glucosamine-labeled G(M2). | Q48212930 | ||
| Glycosphingolipids in fetal Tay-Sachs disease brain and lung cultures | Q48267993 | ||
| GM2 ganglioside in fetal Tay-Sachs disease brain cultures: a model system for the disease | Q48375488 | ||
| P433 | issue | 1 | |
| P921 | main subject | Tay-Sachs disease | Q560337 |
| P304 | page(s) | 9-17 | |
| P577 | publication date | 1980-01-01 | |
| P1433 | published in | Acta Neuropathologica | Q343168 |
| P1476 | title | Enzyme replacement treatment for Tay-Sachs disease brain cells in culture utilizing concanavalin A-mediated hexosaminidase A uptake: biochemical and morphological evidence of GM2 mobilization | |
| P478 | volume | 50 |
| Q41757590 | Biology and potential strategies for the treatment of GM2 gangliosidoses |
| Q34547567 | Characterization of a new model of GM2-gangliosidosis (Sandhoff's disease) in Korat cats |
| Q36370552 | Delivery of hexosaminidase A to the cerebrum after osmotic modification of the blood--brain barrier |
| Q45189355 | Gangliosides in SV-40-transformed cells derived from Tay-Sachs disease fetal brain |
| Q45869915 | Systemic FIV vector administration: transduction of CNS immune cells and Purkinje neurons |
Search more.